Contact Us

Case Review Form
*    Denotes required field.

Describe accident or indicate name of drug or device

   * First Name 

   * Last Name 

   * Email 


   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Nov 17, 2004 | Dow Jones A lawsuit has been filed in State Supreme Court in Manhattan accusing Pfizer, Inc., of failing to adequately and timely warn consumers about the life-threatening side effects associated with its anti-inflammatory drug, Bextra. The suit was filed on behalf of the estate of a 46- year old New Jersey resident; the law firms Parker & Waichman and Seeger Weiss said yesterday.  Bextra was approved in 2001 for treatment of osteoarthritis, adult rheumatoid arthritis and dysmenorrhea.  In October, Pfizer said Bextra was associated with an increase in heart attacks and strokes in two studies of patients taking the drug after heart bypass surgery.  A representative of Pfizer, based in New York, was not immediately available for comment.

Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo